chr2-43814506-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022436.3(ABCG5):āc.1733A>Gā(p.Asn578Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000136 in 1,608,272 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000098 ( 0 hom., cov: 32)
Exomes š: 0.00014 ( 1 hom. )
Consequence
ABCG5
NM_022436.3 missense
NM_022436.3 missense
Scores
12
7
Clinical Significance
Conservation
PhyloP100: 5.23
Genes affected
ABCG5 (HGNC:13886): (ATP binding cassette subfamily G member 5) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. The protein encoded by this gene functions as a half-transporter to limit intestinal absorption and promote biliary excretion of sterols. It is expressed in a tissue-specific manner in the liver, colon, and intestine. This gene is tandemly arrayed on chromosome 2, in a head-to-head orientation with family member ABCG8. Mutations in this gene may contribute to sterol accumulation and atheroschlerosis, and have been observed in patients with sitosterolemia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.17862716).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ABCG5 | NM_022436.3 | c.1733A>G | p.Asn578Ser | missense_variant | 12/13 | ENST00000405322.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ABCG5 | ENST00000405322.8 | c.1733A>G | p.Asn578Ser | missense_variant | 12/13 | 1 | NM_022436.3 | P1 | |
ABCG5 | ENST00000486512.5 | n.2254A>G | non_coding_transcript_exon_variant | 8/9 | 1 | ||||
ABCG5 | ENST00000409962.1 | n.2016A>G | non_coding_transcript_exon_variant | 8/9 | 2 | ||||
ABCG5 | ENST00000644754.1 | n.2117A>G | non_coding_transcript_exon_variant | 9/10 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152214Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
15
AN:
152214
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000299 AC: 75AN: 251024Hom.: 0 AF XY: 0.000265 AC XY: 36AN XY: 135680
GnomAD3 exomes
AF:
AC:
75
AN:
251024
Hom.:
AF XY:
AC XY:
36
AN XY:
135680
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000140 AC: 204AN: 1455940Hom.: 1 Cov.: 28 AF XY: 0.000115 AC XY: 83AN XY: 724704
GnomAD4 exome
AF:
AC:
204
AN:
1455940
Hom.:
Cov.:
28
AF XY:
AC XY:
83
AN XY:
724704
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152332Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74494
GnomAD4 genome
AF:
AC:
15
AN:
152332
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
19
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 22, 2018 | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Sitosterolemia Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 21, 2023 | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 578 of the ABCG5 protein (p.Asn578Ser). This variant is present in population databases (rs146534033, gnomAD 0.2%). This missense change has been observed in individual(s) with hypercholesterolemia (PMID: 29066094). ClinVar contains an entry for this variant (Variation ID: 500473). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
ABCG5-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 07, 2024 | The ABCG5 c.1733A>G variant is predicted to result in the amino acid substitution p.Asn578Ser. This variant has been reported in a one individual with hypercholesterolemia (Table 3, Lamiquiz-Moneo et al. 2017. PubMed ID: 29066094). This variant is reported in 0.18% of alleles in individuals of Latino descent in gnomAD, which may be too common to be a primary cause of disease. While we suspect this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 19, 2021 | The p.N578S variant (also known as c.1733A>G), located in coding exon 12 of the ABCG5 gene, results from an A to G substitution at nucleotide position 1733. The asparagine at codon 578 is replaced by serine, an amino acid with highly similar properties. This variant was detected in two individuals from a Spanish hypercholesterolemia cohort (Lamiquiz-Moneo I et al. J Clin Lipidol Oct;11:1432-1440.e4). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.
REVEL
Uncertain
Sift
Benign
T;.
Sift4G
Uncertain
D;.
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at